SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending as investors debate the impact of the company's aggressive Bitcoin accumulation strategy, which remains a polarizing topic amid recent price volatility. The community is sharply divided between those who view the firm as a high-conviction leveraged play on Bitcoin and critics who express concerns over ongoing share dilution and the stock's sensitivity to broader market risks.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened volatility as retail investors debate whether current price levels represent a significant buying opportunity or a deeper correction fueled by broader market uncertainty and geopolitical concerns. While some in the community are actively organizing around the potential for a short squeeze due to high short interest and borrowing costs, others remain focused on the company's long-term enterprise growth and recent industry recognition.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors focus on the upcoming earnings report and the expected filing of the annual 10-K, with the community closely tracking debt reduction efforts and potential value realization from core holdings like BW. Sentiment remains highly polarized as supporters anticipate a structural turnaround and short squeeze, while others remain cautious due to recent filing delays and ongoing volatility.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is generating intense buzz as investors anticipate high-impact long-term efficacy data from the VELA Phase 3 trials at the upcoming American Academy of Dermatology conference. Community sentiment remains highly bullish, with many participants citing the potential for the drug to be classified as 'best-in-class' and speculating on an inevitable buyout by Big Pharma as institutional interest continues to mount.

WeShop Holdings Ltd. engages in providing a shoppable social network. It offers shopping in fashion and accessories, health and beauty, home and DIY, food and drink, travel and holidays, tech and electronics, and other popular categories. It includes a library of shoppable product reviews from a digital online shopping mall on mobile devices. The company was founded by John Garner on September 21, 2012 and is headquartered in Jersey, the United Kingdom.

WeShop Holdings Ltd - Ordinary Shares - Class A

WeShop Holdings Limited

WeShop Holdings is experiencing intense volatility and speculative interest from retail traders drawn to its unique community-owned, share-based shopping model. The community is actively debating the stock's potential for massive momentum-driven squeezes due to its low float and high borrow rates, while skeptics express concern over its lack of substantial revenue and potential for a rapid rug-pull.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is trending amidst intense market volatility driven by escalating geopolitical tensions in the Middle East and concerns over energy costs, with community debate sharply divided between those viewing the price drops as a deep value accumulation opportunity and others predicting further downside. Investors are closely monitoring institutional flows and staking activities, even as short-term traders grapple with significant liquidations and widespread uncertainty about the asset's near-term decoupling from Bitcoin.

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals is trending following the FDA approval of EMPAVELI for rare kidney diseases, a long-awaited catalyst that de-risks the company and strengthens its nephrology portfolio. The community is actively debating the stock's future, balancing optimism over this label expansion and upcoming earnings with lingering frustration regarding management's past execution and previous revenue guidance challenges.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

SPY is experiencing significant volatility driven by unconfirmed reports of potential peace talks and diplomatic posturing regarding the U.S.-Iran conflict, leading to heavy speculation and aggressive short-squeezing. The market remains deeply divided as participants debate whether this surge represents a genuine de-escalation or a tactical bull trap fueled by institutional liquidity rebalancing.

Invesco QQQ Trust Series 1 - Units of beneficial interest

The Invesco QQQ Trust is experiencing extreme intraday volatility driven by conflicting headlines regarding the conflict in Iran and potential peace negotiations, causing the community to debate whether the recent price action is a genuine recovery or a "bull trap" fueled by market manipulation. Investors remain sharply divided, with many actively trading short-dated options to navigate the news-driven swings while monitoring how oil price stability impacts the tech-heavy index's upward momentum.

Blue Moon Metals Inc. engages in the acquisition and exploration of mineral resource properties. It focuses on Blue Moon zinc and Yava properties. The company was founded on January 15, 2007 and is headquartered in Vancouver, Canada.

Blue Moon Metals Inc

Blue Moon Metals is gaining significant attention due to aggressive expansion through strategic asset acquisitions and a portfolio focused on critical minerals. Investors are closely tracking the company's progress, highlighting the institutional backing and the potential for increased visibility as the firm consolidates key mining infrastructure.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$VKTX 

Yup cause buying $150K in stock with post tax dollars is a bad thing? He even purchased at a price higher than his recent options grants. He clearly sees the price higher in 6-12 months buyout or not…

He’s only been there 6 weeks and already thinks 180K shares isn’t enough exposure…

10% of the GLP market is a mega cap by 2032…

Matei.

KnysnaNow

Dogan

0wl2000

Stock Warrior

Ronald Baker

John

GTL91

RANDY

Wendi

Financiern

$VKTX closes red tomorrow. Todays purchase signals no buy out. Shorts will be back in control once again. Just a opinion. Relax

StockTwits For Android 

Viking Therapeutics Inc

StockTwits for iOS

 

Yup cause buying $150K in stock with post tax dollars is a bad thing? He even purchased at a price higher than his recent options grants. He clearly sees the price higher in 6-12 months buyout or not…

He’s only been there 6 weeks and already thinks 180K shares isn’t enough exposure…

10% of the GLP market is a mega cap by 2032…